MXCT
Rockville, MD 20850
US
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Swirsky Douglas J | S-Sale | 10,142 | $0.81 | 2026-03-17 |
| Swirsky Douglas J | P-Purchase | 50,000 | $1.29 | 2025-08-13 |
| Masoud Maher | P-Purchase | 75,000 | $1.37 | 2025-08-13 |
| Erck Stanley C | P-Purchase | 100,000 | $1.37 | 2025-08-13 |
| DOUGLAS RICHARD | P-Purchase | 80,000 | $1.39 | 2025-08-13 |